Research Output per year
Personal profile
Research interests
Dr. Kevin Rakszawski's research interests include end-of-life care in patients with hematologic malignancies; lymphoma therapeutics; and prevention and treatment of complications of blood and marrow transplantation.
Teaching and educational interests
Dr. Kevin Rakszawski is involved in medical education at a variety of levels. His teaching interests include hematologic malignancies and medical humanities.
Clinical interests
In addition to his clinical practice, Dr. Kevin Rakszawski is a physician champion for the clinical documentation improvement initiative at Penn State Health Milton S. Hershey Medical Center.
Education/Academic qualification
Hematology/Oncology, Fellowship, Penn State Health Milton S. Hershey Medical Center
… → 2019
Internal Medicine, Residency, Penn State Health Milton S. Hershey Medical Center
… → 2016
MD, Penn State College of Medicine
… → 2013
Biomedical Science (minor in Music), BAS, University of Pennsylvania
… → 2009
External positions
Medical Director, The Schwartz Center for Compassionate Healthcare
Fingerprint Dive into the research topics where Kevin L. Rakszawski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 16 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
Eomes+T-betlow CD8+ T cells are functionally impaired and are associated with poor clinical outcome in patients with acute myeloid leukemia
Jia, B., Zhao, C., Rakszawski, K. L., Claxton, D. F., Christopher Ehmann, W., Rybka, W. B., Mineishi, S., Wang, M., Shike, H., Bayerl, M. G., Sivik, J. M., Schell, T. D., Drabick, J. J., Hohl, R. J. & Zheng, H., Apr 1 2019, In : Cancer Research. 79, 7, p. 1635-1645 11 p.Research output: Contribution to journal › Article
Open Access
4
Scopus
citations
Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML
Rakszawski, K. L., Miki, K., Claxton, D., Wagner, H., Shike, H., Mineishi, S. & Naik, S., Sep 1 2018, In : International journal of hematology. 108, 3, p. 348-350 3 p.Research output: Contribution to journal › Article
3
Scopus
citations
Breast implant-associated anaplastic large cell lymphoma: A systematic review
Leberfinger, A. N., Behar, B. J., Williams, N. C., Rakszawski, K. L., Potochny, J. D., MacKay, D. R. & Ravnic, D. J., Dec 2017, In : JAMA Surgery. 152, 12, p. 1161-1168 8 p.Research output: Contribution to journal › Review article
45
Scopus
citations
Association of the extent of resection with survival in glioblastoma a systematic review and meta-Analysis
Brown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K. L., Patel, A. S., Rizk, E. B., Suki, D., Sawaya, R. & Glantz, M., Nov 2016, In : JAMA Oncology. 2, 11, p. 1460-1469 10 p.Research output: Contribution to journal › Article
183
Scopus
citations
Recent advances in pancreatic cancer: Updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology
Abrams, M. J., Rakszawski, K., Vasekar, M., Passero, F., Abbas, A., Jia, Y. & Saif, M. W., Mar 1 2016, In : Therapeutic Advances in Gastroenterology. 9, 2, p. 141-151 11 p.Research output: Contribution to journal › Editorial
5
Scopus
citations
Prizes
Award for Excellence in Research, Internal Medicine Residency
Rakszawski, Kevin L. (Recipient), 2016
Prize